Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

DIVASIL ER

Class 5Status: Accepted & Advertised
Application Number6135170
Trademark Status
Accepted & Advertised
Trademark Class5
Application Date2023-10-04
Proprietor NameSTALK BASIL PHARMACEUTICALS PRIVATE LIMITEDOther
Appropriate OfficeAHMEDABAD
StateGUJARAT
Trademark TypeWORD
User DetailsProposed to be used
Agent NameNIKHIL DHANOTIYA[31112]
Agent Address612-B Rajani Bhawan Opp. High Court, Indore, MP-452001
Goods And Services Details[CLASS : 5] PHARMACEUTICALS

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
DIVASIL ER5Accepted & Advertised
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about DIVASIL ER.

What is the status of trademark application 6135170?
The current status of trademark application 6135170 for DIVASIL ER is Accepted & Advertised.
What is the trademark class of DIVASIL ER?
DIVASIL ER is registered under trademark class 5.
Who is the proprietor of DIVASIL ER?
The proprietor of DIVASIL ER is STALK BASIL PHARMACEUTICALS PRIVATE LIMITEDOther.
When was trademark application 6135170 filed?
Trademark application 6135170 for DIVASIL ER was filed on 2023-10-04.